EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

\ Mycoplasma pneumoniae Infections Among Children and Adolescents in Korea, 2014–2024

Byung Wook Eun iD, Unyeong Go iD, Gayoung Chun iD, Mi-Sun Park iD, You La Jeon iD, Sungwook Song iD, Eun Hee Lee iD, Sang Gon Lee iD

Journal of Korean Medical Science · 2025

DOI: 10.3346/jkms.2025.40.e253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Byung Wook Eun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nowon Eulji University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, Pneumonia, Mycoplasma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Government-wide R&D to Advance Infectious Disease Prevention and Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mycoplasma pneumoniae (MP) is the most common cause of community-acquired bacterial pneumonia in children. Macrolides are used as the first-line treatment for MP infection, but resistance has increased significantly over the past few decades, making treatment difficult. This study examines the prevalence of M. pneumoniae infections and macrolide-resistant M. pneumoniae (MRMP) rates in Korean children across three recent epidemics in Korea between 2014 and 2024. METHODS: Data from Green Cross Laboratories on M. pneumoniae polymerase chain reaction (PCR) and macrolide-resistance tests were analyzed from January 2014 to March 2024, including 425,079 MP PCR tests and 11,206 resistance tests (macrolide-resistance testing began in 2019). We examined M. pneumoniae-positive rates by age and compared age composition to the epidemic and non-epidemic periods using Cochran-Armitage trend tests and also examined differences in MRMP positive rates by year, epidemic status, sex, age group, and region using the χ² test. RESULTS: Three epidemics of M. pneumoniae infection were identified in 2015/16, 2019/20, and 2023/24, with seasonal peaks between the third and fourth quarter of each starting epidemic year and the highest M. pneumoniae-positive rates in children aged 7 to 9 years. There were significant differences in the proportion of children aged 12 years or younger between epidemic and non-epidemic periods (P < 0.001 for two epidemics and 0.027 for one). MRMP PCR positive rates for A2063G and A2064G mutations were 76.6% and 0.7%, respectively, with a notable increase in A2063G rates from 2019/20 to 2023/24, along with a significant decrease as age increased. CONCLUSION: The findings indicate a significant rise in M. pneumoniae infections among Korean children, especially those aged 12 years or younger, suggesting a nationwide epidemic. The increase in A2063G mutation rates underscores the need for monitoring antibiotic resistance and further research into resistance factors for future epidemic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma pneumoniaePneumonia, MycoplasmaHumansChildRepublic of KoreaMaleAdolescentFemaleChild, PreschoolAnti-Bacterial AgentsMacrolidesDrug Resistance, BacterialInfantPrevalenceMicrobial Sensitivity TestsPolymerase Chain ReactionSeasons

Stichwörter der Autor:innen

AdolescentChildMycoplasma pneumoniae

Substanzen

Anti-Bacterial AgentsMacrolides

Autor:innen und Institutionen

  • Department of Pediatrics, Nowon Eulji University Hospital, Seoul, Korea.
  • Infectious Disease Research Center, Green Cross Laboratories, Yongin, Korea.
  • Department of Laboratory Medicine, Green Cross Laboratories, Yongin, Korea.
  • Department of Laboratory Medicine, Green Cross Laboratories, Yongin, Korea. ehlee@gclabs.co.kr.
  • Department of Laboratory Medicine, Green Cross Laboratories, Yongin, Korea. sglee@gclabs.co.kr.

ORCID-Profile: Byung Wook Eun, Unyeong Go, Gayoung Chun, Mi-Sun Park, You La Jeon, Sungwook Song, Eun Hee Lee, Sang Gon Lee

Förderung

  • The Government-wide R&D to Advance Infectious Disease Prevention and Control

Zitieren

APA

Eun, B. W., Go, U., Chun, G., Park, M. S., Jeon, Y., Song, S., Lee, E. H., & Lee, S. G. (2025). \ Mycoplasma pneumoniae Infections Among Children and Adolescents in Korea, 2014–2024. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2025.40.e253

Vancouver

Eun BW, Go U, Chun G, Park MS, Jeon Y, Song S, et al. \ Mycoplasma pneumoniae Infections Among Children and Adolescents in Korea, 2014–2024. Journal of Korean Medical Science. 2025. doi:10.3346/jkms.2025.40.e253

BibTeX
@article{Eun2025,
  author = {Eun, Byung Wook and Go, Unyeong and Chun, Gayoung and Park, Mi-Sun and Jeon, You La and Song, Sungwook and Lee, Eun Hee and Lee, Sang Gon},
  title = {\ Mycoplasma pneumoniae Infections Among Children and Adolescents in Korea, 2014–2024},
  journal = {Journal of Korean Medical Science},
  year = {2025},
  doi = {10.3346/jkms.2025.40.e253}
}
Kostenlos starten →